EMEA Liquid Biopsy Market Trends and Forecast 2028: Growth & Market Size

The EMEA Liquid Biopsy Market is projected to grow at a CAGR of around 13.98% during the forecast period, 2023-28.                                               

EMEA Liquid Biopsy Market Dynamics:

Prevalence in the Number of Cancer Patients Would Generate the Demand for Liquid Biopsy – Cancer has been a chronic disease over the past years & would continue to ascend in the forecasting year as well, owing to the increasingly sedentary lifestyle, smoking, and drinking habit of the individual, which would require better diagnostic facilities, treatment, and care for the patients. The continuous boost in the number of cancer patients emphasizes the need for accurate & convenient diagnostic systems for early cancer detection. Consequently, with the rising number of cancer patients, especially across Turkey, France, Denmark, etc., the usage of Liquid Biopsy is also uplifting. The advantages of liquid biopsy, like lower cost, early prognosis, therapy monitoring, etc., have further enhanced their adoption over conventional diagnostic methods to detect urothelial carcinoma, non-urological cancers, and other blood cancers.

The use of liquid biopsy has also been upscale to determine the best treatments for cancer patients, especially lung & prostate cancer, in which the patient receives specific targeted drugs. Hence, the improved investments by government organizations & pharmaceutical companies to escalate the research & development of new cancer treatments are anticipated to augment the growth of the EMEA Liquid Biopsy Market during the forecasted period.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/emea-liquid-biopsy-market.html

Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. 

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/emea-liquid-biopsy-market.html

EMEA Liquid Biopsy Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2022

-Historical Period: 2018 to 2021

-Forecast Period: 2023-28

• By Product and Services
  • Equipment
  • Assay Kits
  • Services
• By Circulating Biomarker
  • Circulating Tumour Cell (CTC)
  • Circulating Tumour DNA (ctDNA)
  • Cell Free DNA (cfDNA)
  • Extracellular Vesicle (EVS)
• By Technology
  • Multi gene analysis by Next Generation Sequencing (NGS)
  • Single gene analysis by Polymer chase reaction (PCR)
•  By Sample Type
  • Blood
  • Urine
  • Others (Cerebrospinal Fluid, Plasma, Saliva, etc.)
• By Application
  • By Cancer Application
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Melanoma cancer
    • Others (Pancreatic, Liver, etc.)
  • By Non Cancer Application
    • Non Invasive Parental Testing
    • Organ Transplantation
    • Infectious Diseases
  • By Clinical Application
    • Early Cancer Screening
    • Therapy Selection
    • Treatment Monitoring
    • Recurrence Monitoring
• By End User
  • Hospital and Physician laboratories
  • Reference Laboratories
  • Academic & Research Centre
• By Country
  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Saudi Arabia
  • The UAE
  • Egypt
  • South Africa

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Thermofisher Scientific, Hoffmann-La Roche Ltd, Sysmex Corporation, Qiagen N.V., Guardant Health, Bio Rad, Neo Genomics, Epigenomics, Menarini-Silicon Biosystems, Agena Bioscience Inc., Silicon Biosystems, Pathway Genomics Corporation, Illumina Inc., Myraid Genetics., Others

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/request-customization/emea-liquid-biopsy-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release